semaglutide for the treatment of obesity An Ongoing Crisis: Shortage Raises Dual Concerns and Diabetes Semaglutide, also known as Ozempic,

10.1073/pnas.1804932115 120 RameshP.JagadeesanR.SekaranS.DhanasekaranA.VimalrajS

We recently identified a novel mechanism by which specific intestinal bacteria promote PCa through insulin-like growth factor I (IGF-1) signaling ( Mechanism of IGF-1 Signaling IGF-1 is a growth factor that plays a crucial role in cell proliferation and physical growth

However, compounded medications are not FDA-approved, as their safety and efficacy are not subject to the same level of regulatory scrutiny

Notably, these pathways facilitate inter-organ inflammatory crosstalk, establishing positive feedback loops among the heart, kidneys, and metabolic tissues